| Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. | 19022547 | PMC2682551 | Journal | 2009 | 10.1053/j.ajkd.2008.08.010 | FAVORIT | | Contributing Study |
| Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial. | 31179500 | PMC6694012 | Journal | 2019 | 10.1093/ajh/hpz095 | FAVORIT | 21306 | Secondary Research |
| Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT). | 22153382 | PMC4410356 | Journal | 2012 | 10.1053/j.jrn.2011.07.009 | FAVORIT | | Contributing Study |
| Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. | 21482964 | PMC4887854 | Journal | 2011 | 10.1161/CIRCULATIONAHA.110.000588 | FAVORIT | | Contributing Study |
| Hypothesis: Potential Utility of Serum and Urine Uromodulin Measurement in Kidney Transplant Recipients? | 29184908 | PMC5682764 | Journal | 2017 | 10.1097/TXD.0000000000000737 | FAVORIT | 21306 | Secondary Research |
| Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study. | 22775763 | PMC4388027 | Journal | 2012 | 10.1111/j.1399-0012.2012.01676.x | FAVORIT | | Contributing Study |
| Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. | 22594581 | PMC3424309 | Journal | 2012 | 10.1111/j.1600-6143.2012.04101.x | FAVORIT | | Contributing Study |
| Physical Activity and Cardiovascular Risk among Kidney Transplant Patients | 30629045 | PMC6522300 | Journal | 2019 | 10.1249/MSS.0000000000001886 | FAVORIT | 21306 | Secondary Research |
| Racial Differences in Medication Utilization for Secondary Prevention of Cardiovascular Disease in Kidney Transplant Recipients: A Post Hoc Analysis of the FAVORIT Trial Cohort. | 35360084 | PMC8961224 | Journal | 2022 | 10.1016/j.xkme.2022.100438 | FAVORIT | 21726 | Secondary Research |
| Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. | 16923411 | | Journal | 2006 | 10.1016/j.ahj.2006.03.004 | FAVORIT | | Contributing Study |
| Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials. | 27375287 | PMC5841614 | Journal | 2016 | 10.1093/ije/dyw118 | SISTEr, DPP, FAVORIT, HEMO, MTOPS, ATN, HALT-C | 6371, 6372, 6830, 8068, 8148, 8168, 8169, 8170 | Secondary Research |
| Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure. | 29698955 | PMC6754623 | Journal | 2018 | 10.1159/000489095 | FAVORIT | 21306 | Secondary Research |
| The Kidney Failure Risk Equation for Prediction of Allograft Loss in Kidney Transplant Recipients. | 33319199 | PMC7729246 | Journal | 2020 | 10.1016/j.xkme.2020.09.004 | FAVORIT | 21726 | Secondary Research |
